Myriad Genetics Inc. Earnings

Myriad Genetics Inc.’s revenue fell -3.56% since last year same period to $205.7Mn in the Q3 2025. On a quarterly growth basis, Myriad Genetics Inc. has generated -3.47% fall in its revenue since last 3-months.

Myriad Genetics Inc.’s net profit fell -23.98% since last year same period to $-27.4Mn in the Q3 2025. On a quarterly growth basis, Myriad Genetics Inc. has generated 91.71% jump in its net profits since last 3-months.

Myriad Genetics Inc.’s net profit margin fell -28.56% since last year same period to -13.32% in the Q3 2025. On a quarterly growth basis, Myriad Genetics Inc. has generated 91.41% jump in its net profit margins since last 3-months.

Myriad Genetics Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.01 - a -16% fall from last quarter’s estimates.

Myriad Genetics Inc.’s earning per share (EPS) estimates for the current year stand at -0.01.

Myriad Genetics Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Myriad Genetics Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.